Bayer nears 7-year low after $2 billion award in Roundup trial

Bayer shares fell by as much as 5 percent on Tuesday after a California couple were awarded more than $2 billion in the largest U.S. jury penalty over allegations its Roundup weed killer causes cancer.

Leave a Reply

Read the original at Reuters: Business News.